Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $52

Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $52

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $50 to $52.

byBenzinga Newsdesk

August 1, 2022

1 minute read

Barclays analyst Carter Gould maintains Pfizer (NYSE:PFE) with a Equal-Weight and raises the price target from $50 to $52.

Analyst Ratings

Where Hub Group Stands With Analysts

By Benzinga Insights

April 10, 5:00 PM

Across the recent three months, 8 analysts have shared their insights on Hub Group (NASDAQ:HUBG), expressing a variety…

HUBG

Ultimate Sweet Treat – Krispy Kreme Partners With Chocolate Brand M&M’S In US

By Shivani Kumaresan

July 17, 7:42 AM

Krispy Kreme Inc (NASDAQ: DNUT) has partnered with chocolate brand M&M'S in the U.S.

DNUT

Analyst Ratings

Deutsche Bank Maintains Buy Rating for Six Flags Entertainment: Here’s What You Need To Know

By Benzinga Insights

May 9, 1:00 PM

Deutsche Bank has decided to maintain its Buy rating of Six Flags Entertainment (NYSE:SIX) and raise its price…

SIX

Dormant Bitcoin Whale Springs Back To Life With $74M Binance Deposit

By Mehab Qureshi

April 8, 6:38 AM

A Bitcoin (CRYPTO: BTC) whale, dormant for the last eight months, transferred a huge sum of Bitcoin to Binance, the world’s largest cryptocurrency exchange.

BTC

Barclays Maintains Equal-Weight on Pfizer, Raises Price Target to $52

Related Posts

Where Hub Group Stands With Analysts

Ultimate Sweet Treat – Krispy Kreme Partners With Chocolate Brand M&M’S In US

Deutsche Bank Maintains Buy Rating for Six Flags Entertainment: Here’s What You Need To Know

Dormant Bitcoin Whale Springs Back To Life With $74M Binance Deposit